PLXNB2 and schizophrenia: In this sense, although we did not observe overt changes in number and morphology of astrocytes by mAb102, we did find reduced GFAP+astrocytes and therefore the potential contribution of astrocytic Plxnb2 to schizophrenia and stress disorders is worth pursuing more carefully in the future.